Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6949)
All Articles published online
|
Publishing Process of This Article
|
Sep 7, 2020 (publication date) through Jun 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Saeki C, Saito M, Oikawa T, Nakano M, Torisu Y, Saruta M, Tsubota A. Effects of denosumab treatment in chronic liver disease patients with osteoporosis. World J Gastroenterol 2020; 26(33): 4960-4971 [PMID: 32952342 DOI: 10.3748/wjg.v26.i33.4960] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i33/4960.htm |
| Number | Citing Articles |
| 1 |
Mohamed Abdalbary, Mahmoud Sobh, Mostafa Abdelsalam, Amr El-Husseini Mohamed. Impact of Liver Cirrhosis on Bone Metabolism. Digestive Disease Interventions 2022; 6(02): 137 doi: 10.1055/s-0042-1743554
|
| 2 |
Sadaf Afraz, Nikhil Kapila. Endocrinology for the hepatologist. Clinical Liver Disease 2023; 22(1): 1 doi: 10.1097/CLD.0000000000000037
|
| 3 |
Norikazu Toi, Yasuo Imanishi, Yuki Nagata, Masafumi Kurajoh, Tomoaki Morioka, Tetsuo Shoji, Yoshitaka Shinto, Masanori Emoto. Improvement in the mobility of a patient with fibroblast growth factor 23-related hypophosphatemic osteomalacia and decompensated liver cirrhosis in response to burosumab: a case report. Endocrine Journal 2023; 70(4): 419 doi: 10.1507/endocrj.EJ22-0520
|
| 4 |
Chisato Saeki, Tomoya Kanai, Kaoru Ueda, Masanori Nakano, Tsunekazu Oikawa, Yuichi Torisu, Masayuki Saruta, Akihito Tsubota. Osteosarcopenia predicts poor survival in patients with cirrhosis: a retrospective study. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02835-y
|
| 5 |
V. M. Zhdan, I. V. Ivanytsky , M. Yu. Babanina, L. M. Shilkina . Optimization of Antiosteoporotic Therapy in Patients with Liver Fibrosis. Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 2021; 6(6): 100 doi: 10.26693/jmbs06.06.100
|
| 6 |
Chisato Saeki, Akihito Tsubota. Influencing Factors and Molecular Pathogenesis of Sarcopenia and Osteosarcopenia in Chronic Liver Disease. Life 2021; 11(9): 899 doi: 10.3390/life11090899
|
| 7 |
Jinxin Lu, Lingling Hu, Liangliang Guo, Jian Peng, Yinghui Wu. The Effects of Claw Health and Bone Mineral Density on Lameness in Duroc Boars. Animals 2023; 13(9): 1502 doi: 10.3390/ani13091502
|
| 8 |
Yusuke Kunimoto, Ryosuke Matamura, Hiroshi Ikeda, Hiroto Horiguchi, Satoshi Fujii, Masayoshi Kobune, Masahide Fukudo, Takaki Toda. Adherence of denosumab treatment for low bone mineral density in Japanese people living with HIV: a retrospective observational study. Journal of Pharmaceutical Health Care and Sciences 2023; 9(1) doi: 10.1186/s40780-023-00315-9
|
| 9 |
Daniel Anthony DiLeo, Tolga Gidener, Ayse Aytaman. Chronic Liver Disease in the Older Patient—Evaluation and Management. Current Gastroenterology Reports 2023; 25(12): 390 doi: 10.1007/s11894-023-00908-2
|
| 10 |
Chisato Saeki, Mitsuru Saito, Tomoya Kanai, Masanori Nakano, Tsunekazu Oikawa, Yuichi Torisu, Masayuki Saruta, Akihito Tsubota, Pavel Strnad. Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease. PLOS ONE 2021; 16(4): e0249728 doi: 10.1371/journal.pone.0249728
|
| 11 |
Chisato Saeki, Mitsuru Saito, Akihito Tsubota. Association of chronic liver disease with bone diseases and muscle weakness. Journal of Bone and Mineral Metabolism 2024; doi: 10.1007/s00774-023-01488-x
|
| 12 |
Aikaterini Gkoufa, Anna Angelousi, Antonia Neonaki, Fani Athanasouli, Evangelos Cholongitas. Severe Symptomatic Hypocalcemia Associated With Denosumab Administration in a Patient With Decompensated Cirrhosis and Renal Dysfunction. Annals of Pharmacotherapy 2022; 56(7): 853 doi: 10.1177/10600280211050216
|
| 13 |
Yuan Liu, Mengqin Yuan, Jian He, Longjiao Cai, Aimin Leng. The Impact of Non-alcohol Fatty Liver Disease on Bone Mineral Density is Mediated by Sclerostin by Mendelian Randomization Study. Calcified Tissue International 2024; 114(5): 502 doi: 10.1007/s00223-024-01204-5
|
| 14 |
Alessandra Musio, Federica Perazza, Laura Leoni, Bernardo Stefanini, Elton Dajti, Renata Menozzi, Maria Letizia Petroni, Antonio Colecchia, Federico Ravaioli. Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease. International Journal of Molecular Sciences 2023; 24(8): 7517 doi: 10.3390/ijms24087517
|